Scholar Rock Holding Corporation (SRRK): Price and Financial Metrics


Scholar Rock Holding Corporation (SRRK)

Today's Latest Price: $13.99 USD

1.26 (-8.26%)

Updated Feb 27 5:21pm

Add SRRK to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 338 in Biotech

See all "A" rated Strong Buy stocks

SRRK Stock Summary

  • Scholar Rock Holding Corp's stock had its IPO on May 24, 2018, making it an older stock than only 3.1% of US equities in our set.
  • With a year-over-year growth in debt of 797.74%, Scholar Rock Holding Corp's debt growth rate surpasses 96.96% of about US stocks.
  • As for revenue growth, note that SRRK's revenue has grown 315.94% over the past 12 months; that beats the revenue growth of 97.73% of US companies in our set.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Scholar Rock Holding Corp are DRNA, BLCM, ADXS, MEIP, and NOVN.
  • Visit SRRK's SEC page to see the company's official filings. To visit the company's web site, go to www.scholarrock.com.
SRRK Daily Price Range
SRRK 52-Week Price Range

SRRK Stock Price Chart More Charts


SRRK Price/Volume Stats

Current price $13.99 52-week high $23.35
Prev. close $15.25 52-week low $6.95
Day low $13.92 Volume 112,100
Day high $15.46 Avg. volume 88,569
50-day MA $12.59 Dividend yield N/A
200-day MA $12.36 Market Cap 415.20M

Scholar Rock Holding Corporation (SRRK) Company Bio


Scholar Rock Holding Corporation discovers and develops a class of biologic therapies that selectively target dysregulated growth factors in the disease microenvironment by modulating supracellular activation. The company’s drug discovery programs target growth factors which are present in the microenvironments of significant diseases, including fibrosis, musculoskeletal diseases, immuno-oncology, and autoimmune diseases. Its lead products include SRK-015, a selective and local inhibitor of latent myostatin activation for the treatment of primary myopathies. The company was founded in 2012 and is based in Cambridge, Massachusetts.


SRRK Latest News Stream


Event/Time News Detail
Loading, please wait...

SRRK Latest Social Stream


Loading social stream, please wait...

View Full SRRK Social Stream

SRRK Price Returns

1-mo 17.56%
3-mo 64.39%
6-mo 32.11%
1-year -24.87%
3-year N/A
5-year N/A
YTD 6.15%
2019 -42.62%
2018 N/A
2017 N/A
2016 N/A
2015 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.647 seconds.